Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a biotechnology firm specializing in pharmaceutical preparations with a market capitalization of $1.12 billion, announced a recent change to its Board of ...
Some results have been hidden because they may be inaccessible to you